Atorvastatin

Managing cholesterol effectively is one of the most important steps in reducing the long-term risk of heart attack and stroke. Atorvastatin tablets are a prescription-only statin used in adults and children aged ten and over for cholesterol control and the prevention of cardiovascular events. Atorvastatin reduces LDL cholesterol (low-density lipoprotein, often called "bad" cholesterol), lowers triglyceride levels, and raises HDL cholesterol, making it a well-established medicine in cardiovascular therapy and lipid management. A prescription can only be issued following a clinical consultation.

Atorvastatin tablets are an oral prescription medicine containing Atorvastatin calcium as the active ingredient. Atorvastatin belongs to the statin class of lipid-lowering medicines, also known as HMG-CoA reductase inhibitors. Statins are the most widely recommended class of cholesterol-lowering medicines in NICE guidance for both primary and secondary prevention of cardiovascular disease in adults.

Atorvastatin is licensed in the UK for treatment of hyperlipidaemia (elevated blood lipids including raised LDL cholesterol and triglycerides) and mixed dyslipidaemia in adults and in children aged ten and over, when dietary measures have been insufficient. It is also licensed for the primary prevention of cardiovascular events in adults without established cardiovascular disease but who have an elevated risk, and for secondary prevention in adults with established cardiovascular disease. The cardiovascular risk reduction indication means Atorvastatin may be prescribed for heart health even when cholesterol levels are not dramatically elevated, if overall cardiovascular risk warrants treatment.

Atorvastatin is available as a generic medicine from multiple manufacturers in four strengths: 10 mg, 20 mg, 40 mg, and 80 mg. The branded version is Lipitor, but generic Atorvastatin is widely dispensed in the UK.

Atorvastatin lowers cholesterol by inhibiting the enzyme responsible for the rate limiting step in the body's own cholesterol production.

HMG-CoA Reductase Inhibition. The liver produces cholesterol through a multi-step pathway. A key early step in this pathway is catalysed by the enzyme HMG-CoA reductase. Atorvastatin selectively and competitively inhibits this enzyme. By blocking HMG-CoA reductase, Atorvastatin reduces the amount of cholesterol produced inside liver cells. In response to reduced intracellular cholesterol, liver cells increase the number of LDL receptors on their surface. These receptors capture more LDL cholesterol from the bloodstream, further lowering circulating LDL levels.

Effect on Blood Lipids. The combined effect of reduced cholesterol synthesis and increased LDL receptor activity produces a significant reduction in LDL cholesterol. Atorvastatin also reduces triglyceride levels and produces a modest increase in HDL cholesterol. The degree of LDL reduction depends on the dose: higher doses produce greater LDL reduction. Atorvastatin is considered a high-intensity statin at the 40 mg and 80 mg doses, meaning it is expected to produce an LDL reduction of 40 per cent or more from baseline, consistent with NICE guideline NG238 recommendations.

Beyond cholesterol lowering, statins including Atorvastatin have additional cardiovascular protective effects, sometimes described as pleiotropic effects. These include improvements in endothelial function, anti inflammatory effects, and stabilisation of atherosclerotic plaques. These mechanisms contribute to the cardiovascular risk reduction seen in large clinical trials such as CARDS and TNT, which form part of the evidence base for atorvastatin's licensed indications.

Always take Atorvastatin exactly as your prescriber instructs. Read the Patient Information Leaflet supplied with your medicine before starting treatment.

• Take Atorvastatin once daily, at any time of day. Unlike some other statins, its long half-life means the timing does not significantly affect effectiveness.
• Atorvastatin can be taken with or without food.
• Swallow the tablet whole with a glass of water.
• Avoid large quantities of grapefruit juice during treatment, as it inhibits CYP3A4 and can increase Atorvastatin blood levels, raising the risk of side effects including muscle problems.

If you miss a dose, take it as soon as you remember on the same day. If you only remember the following day, skip the missed dose and continue as normal. Do not take two doses on the same day. Do not stop taking Atorvastatin without speaking to your prescriber first, as cholesterol management and cardiovascular risk reduction require long term treatment.

Your prescriber will arrange a blood test to check your lipid levels before starting treatment and again after eight to twelve weeks to assess your response. Liver function may also be checked.

Atorvastatin tablets are available in four strengths. The appropriate dose is determined by your prescriber based on your lipid levels, cardiovascular risk, and individual response to treatment.

Atorvastatin 10 mg Tablets: The lowest available strength. May be used as a starting dose in patients who may be more sensitive to statins, such as older patients or those starting statin therapy cautiously. Classified as a low intensity statin dose.

Atorvastatin 20 mg Tablets: Within the medium intensity statin dose range. May be appropriate for patients requiring moderate LDL reduction or stepping up from 10 mg. NICE guideline NG238 recommends high intensity statin doses for most adults eligible for primary or secondary prevention; 20 mg may suit specific patient groups where high intensity doses are not suitable.

Atorvastatin 40 mg Tablets: A high intensity statin dose. NICE NG238 recommends 20 mg for primary prevention and 80 mg for secondary prevention, but 40 mg is clinically used when a patient requires high intensity statin therapy but cannot tolerate 80 mg. One of the most commonly prescribed strengths.

Atorvastatin 80 mg Tablets: The maximum dose, classified as a high intensity statin dose. NICE NG238 recommends 80 mg for secondary prevention in adults with established cardiovascular disease, as this dose produces the greatest LDL reduction. Do not change your dose without medical advice.

Like all medicines, Atorvastatin can cause side effects.

Common Side Effects (may affect up to 1 in 10 people):

• Muscle aches, pains, or weakness (myalgia) — the most commonly reported statin side effect. Contact your prescriber if you experience unexplained muscle pain, tenderness, or weakness, particularly with dark urine.
• Gastrointestinal effects including nausea, diarrhoea, constipation, or abdominal pain.
• Headache.
• Elevated liver enzymes on blood tests, usually asymptomatic and monitored by periodic liver function tests.

Uncommon Side Effects (may affect up to 1 in 100 people):

• Abnormal blood glucose levels — statins are associated with a small increase in the risk of developing type 2 diabetes, outweighed by cardiovascular benefit in eligible patients.
• Sleep disturbances or insomnia.
• Memory problems or cognitive effects, generally mild and reversible.

Serious Side Effects — Seek Urgent Medical Attention: Go to your nearest accident and emergency department or call 999 immediately if you experience myopathy or rhabdomyolysis (severe muscle pain, weakness, or cramps, particularly with dark, tea coloured urine), signs of serious liver problems such as yellowing of the skin or eyes, severe abdominal pain or very dark urine, or signs of a severe allergic reaction such as sudden swelling of the face, lips, tongue, or throat, or difficulty breathing.

Atorvastatin tablets may be suitable if you:

• Are an adult or a young person aged 10 or over with elevated LDL cholesterol or mixed dyslipidaemia that has not responded adequately to dietary measures.
• Are an adult with an elevated cardiovascular risk and your prescriber has recommended a statin for primary prevention based on your overall risk assessment.
• Have established cardiovascular disease (such as a history of heart attack, stroke, or angina) and are eligible for secondary prevention statin therapy.
• Are already prescribed Atorvastatin and require a repeat prescription through an online prescribing service.

Atorvastatin tablets are not suitable if you:

• Are pregnant or planning to become pregnant. Atorvastatin is contraindicated in pregnancy as cholesterol synthesis inhibition may harm the developing baby. Effective contraception is required during treatment and for one month after stopping.
• Are breastfeeding.
• Have active liver disease or persistently elevated liver enzymes of unknown cause.
• Have a known allergy or hypersensitivity to Atorvastatin or any excipient listed in the SmPC.

Important Drug Interactions: Ciclosporin, some HIV or hepatitis C medicines (protease inhibitors), and certain antifungals (itraconazole, ketoconazole) significantly increase Atorvastatin blood levels and raise the risk of muscle problems — some combinations are contraindicated. Fibrates such as gemfibrozil increase the risk of myopathy and rhabdomyolysis; gemfibrozil is contraindicated. Colchicine increases the risk of myopathy. Grapefruit juice in large quantities increases Atorvastatin blood levels. Warfarin and other anticoagulants may have their effect modestly increased — INR monitoring is recommended. Digoxin levels may be slightly increased.

Atorvastatin is a Prescription Only Medicine. The clinical consultation is the essential first step. A prescription will only be issued if a registered prescriber concludes, based on their individual assessment of your circumstances, that Atorvastatin is clinically appropriate for you.

During your online consultation with Pharmacy Planet, a registered prescriber will review your cholesterol levels or cardiovascular risk assessment, relevant medical history, current medicines, and any other relevant information. The prescriber will determine which strength is appropriate, whether Atorvastatin or a different statin better suits your needs, and whether online prescribing is appropriate for your situation.

Not all consultations will result in a prescription. The prescriber may request recent blood test results, recommend a different statin or approach, or advise that a full cardiovascular risk assessment by your GP is needed before prescribing proceeds.

If you are under the care of your GP, cardiologist, or a specialist for cholesterol control or cardiovascular therapy, please keep them informed of all medicines prescribed through online services.